| P2093 | author name string | Adolf E Schindler | |
| P2860 | cites work | Risk of cancer in women receiving hormone replacement therapy | Q69385385 |
| | Estrogen replacement therapy and fatal ovarian cancer | Q72157255 |
| | Estrogen replacement therapy for ovarian carcinoma survivors: A randomized controlled trial | Q73004908 |
| | Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines | Q73335132 |
| | ERT for survivors of endometrial cancer? A new trial will resolve debate | Q73337252 |
| | Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study | Q73384879 |
| | Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix | Q73598508 |
| | Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40 | Q73645480 |
| | Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens | Q74178932 |
| | Hormonal therapy following female genital tract cancer | Q74572783 |
| | Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis | Q77168041 |
| | Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma | Q77321080 |
| | Hormone replacement therapy in women treated for gynaecological malignancy. | Q33721631 |
| | Incessant ovulation--a factor in ovarian neoplasia? | Q34051579 |
| | Hormone replacement therapy and survival after surgery for ovarian cancer | Q35178365 |
| | Hormone replacement and cancer | Q35543135 |
| | Case-control study of oestrogen replacement therapy and risk of cervical cancer | Q36245388 |
| | Hormone replacement therapy and risk of epithelial ovarian cancer. | Q36619751 |
| | Estrogen replacement therapy: is previously treated cancer a contraindication? | Q37627286 |
| | Hormone replacement therapy and endometrial cancer risk: a meta-analysis | Q40571296 |
| | Adjuvant progestagen therapy for the treatment of endometrial cancer: review and meta-analyses of published randomised controlled trials | Q41055264 |
| | Estrogen replacement in surgical stage I and II endometrial cancer survivors | Q41243007 |
| | Therapy with gestagens in hyperplastic changes of the endometrium | Q44084322 |
| | Estrogen replacement therapy following treatment for stage I endometrial carcinoma | Q44225710 |
| | Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort | Q48960509 |
| | Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. | Q50672431 |
| | Megestrol Acetate for the Prevention of Hot Flashes | Q56690205 |
| | Long-term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy | Q58218274 |
| | Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer | Q68307960 |
| | Hormonal replacement therapy in patients after cervical cancer treatment | Q68983037 |
| P921 | main subject | Hormone Replacement Therapy | Q108667313 |
| P304 | page(s) | S105-11 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Maturitas | Q15766577 |
| P1476 | title | Hormone replacement therapy (HRT) in women after genital cancer | |
| P478 | volume | 41 Suppl 1 | |